Irvine, California
United States
24
2023-06-29
17
2022-05-31
These are the the leading inventors for applications assigned to ChromaDex Inc.:
ChromaDex Inc. based in Irvine, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
USE OF NICOTINAMIDE RIBOSIDE, NICOTINIC ACID RIBOSIDE, AND NICOTINAMIDE MONONUCLEOTIDE, REDUCED NICOTINYL COMPOUNDS, AND NICOTINOYL COMPOUND DERIVATIVES IN INFANT FORMULA FOR HEALTHY DEVELOPMENT
#2 | 2022-08-04ETHYL CELLULOSE BASED COATINGS FOR MICROENCAPSULATION OF NICOTINAMIDE RIBOSIDE, NICOTINIC ACID RIBOSIDE, REDUCED NICOTINYL RIBOSIDE COMPOUNDS, AND NICOTINYL RIBOSIDE COMPOUND DERIVATIVES
#3 | 2022-04-07 ✅ Patent 11,345,720 granted on 2022-05-31Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof
#4 | 2022-02-08 ✅ Patent 11,242,364 granted on 2022-02-08Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof
#5 | 2021-11-25 ✅ Patent 11,274,117 granted on 2022-03-15Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof
#6 | 2021-11-11 ✅ Patent 11,746,123 granted on 2023-09-05Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof
#7 | 2021-07-29 ✅ Patent 11,524,022 granted on 2022-12-13Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy development
#8 | 2020-09-17 ✅ Patent 11,033,568 granted on 2021-06-15Nicotinamide riboside compositions for topical use in treating skin conditions
#9 | 2020-08-27USE OF NICOTINAMIDE RIBOSIDE, NICOTINIC ACID RIBOSIDE, REDUCED NICOTINYL RIBOSIDE COMPOUNDS, AND NICOTINYL RIBOSIDE COMPOUND DERIVATIVES IN FORMULATIONS
#10 | 2020-06-11 ✅ Patent 11,214,589 granted on 2022-01-04Crystalline forms of nicotinoyl ribosides and derivatives thereof, and methods of preparation thereof
#11 | 2018-09-13 ✅ Patent 10,934,322 granted on 2021-03-02B-vitamin and amino acid conjugates of nicotinoyl ribosides and reduced nicotinoyl ribosides, derivatives thereof, and methods of preparation thereof
#12 | 2018-05-17 ✅ Patent 10,689,411 granted on 2020-06-23Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof
#13 | 2018-05-17 ✅ Patent 9,975,915 granted on 2018-05-22Crystalline forms of nicotinoyl ribosides, modified derivatives thereof, and phosphorylated analogs thereof, and methods of preparation thereof
#14 | 2017-10-26 ✅ Patent 10,183,036 granted on 2019-01-22Use of nicotinic acid riboside or nicotinamide riboside derivatives, and reduced derivatives thereof, as NAD+ increasing precursors
#15 | 2017-10-19 ✅ Patent 10,857,172 granted on 2020-12-08Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy development
#16 | 2017-09-21 ✅ Patent 10,000,520 granted on 2018-06-19B-vitamin and amino acid conjugates ofnicotinoyl ribosides and reduced nicotinoyl ribosides, derivatives thereof, and methods of preparation thereof
#17 | 2016-12-08SELECTIVE SOLVENT FREE PHOSPHORYLATION
#18 | 2016-09-22 ✅ Patent 10,280,190 granted on 2019-05-07Nicotinic acid riboside or nicotinamide riboside compositions, reduced derivatives thereof, and the use thereof to enhance skin permeation in treating skin conditions
#19 | 2016-09-01 ✅ Patent 10,688,118 granted on 2020-06-23Nicotinamide riboside compositions for topical use in treating skin conditions
#20 | 2015-01-08 ✅ Patent 10,039,725 granted on 2018-08-07Method for treating non-melanoma skin cancer by inducing UDP-glucuronosyltransferase activity using pterostilbene
#21 | 2013-11-07PTEROSTILBENE AND CURCUMIN COMBINATION FOR TREATMENT OF OXIDATIVE STRESS AND INFLAMMATION
#22 | 2013-06-13PTEROSTILBENE AND PVP GRAPE JUICE EXTRACT COMBINATION FOR TREATMENT OF METABOLIC, VASCULAR, AND NEURODEGENERATIVE DISORDERS
#23 | 2013-03-21PTEROSTILBENE AND STATIN COMBINATION FOR TREATMENT OF METABOLIC DISEASE, CARDIOVASCULAR DISEASE, AND INFLAMMATION
#24 | 2012-11-15 ✅ Patent 8,841,350 granted on 2014-09-23Method for inducing UDP-glucuronosyltransferase activity using pterostilbene
Also check out ChromaDex Inc.'s (Irvine, United States) applicant profile with 16 patent applications submitted.
14986 ⎘